The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552
Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., Carson, P., DiCarlo, L., DeMets, D., White, B. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032423 · Cited by 5,812
Self-citationCardiac Resynchronization in Chronic Heart Failure
Abraham, W. T., Fisher, W. G., Smith, A. L., Delurgio, D. B., Leon, A. R., Loh, E., Kocovic, D. Z., Packer, M., Clavell, A. L., Hayes, D. L., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013168 · Cited by 4,648
Self-citationA comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
Cohn, J. N., & Tognoni, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010713 · Cited by 3,108
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., Fowler, M. B., Katus, H. A., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Castaigne, A., Roecker, E. B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442201 · Cited by 3,093
The effect of digoxin on mortality and morbidity in patients with heart failure
(1997) · New England Journal of Medicine · doi:10.1056/nejm199702203360801 · Cited by 3,016
Cohn, J. N., Johnson, G., Ziesche, S., Cobb, F., Francis, G., Tristani, F., Smith, R., Dunkman, W. B., Loeb, H., Wong, M., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250502 · Cited by 2,833
Self-citation
Research works printed but not linked: 311
- Hunt, 2005, J Am Coll Cardiol, 46, e1, 10.1016/j.jacc.2005.08.022 · DOI · Paper page
- Jessup, 2008, 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of chronic heart failure in adults with the 2008 focused update incorporated, J Am Coll Cardiol, 53, e1
- Alderman, 1983, Results of coronary artery surgery in patients with poor left ventricular function (CASS), Circulation, 68, 785, 10.1161/01.CIR.68.4.785 · DOI · Paper page
- Eagle, 2004, Circulation, 110, e340
- Fox, 2001, Coronary artery disease as the cause of incident heart failure in the population, Eur Heart J, 22, 228, 10.1053/euhj.2000.2289 · DOI · Paper page
- Arques, 2004, Prevalence of angiographic coronary artery disease in patients hospitalized for acute diastolic heart failure without clinical and electrocardiographic evidence of myocardial ischemia on admission, Am J Cardiol, 94, 133, 10.1016/j.amjcard.2004.03.046 · doi:10.1016/j.amjcard.2004.03.046
- Kurtz, 2006, Use of ejection fraction tests and coronary angiography in patients with heart failure, Mayo Clin Proc, 81, 906, 10.4065/81.7.906 · DOI
- Elhendy, 2004, Incidence and predictors of heart failure during long-term follow-up after stress Tc-99m sestamibi tomography in patients with suspected coronary artery disease, J Nucl Cardiol, 11, 527, 10.1016/j.nuclcard.2004.04.011 · DOI
- Chomsky, 1996, Hemodynamic exercise testing, Circulation, 94, 3176, 10.1161/01.CIR.94.12.3176 · DOI · Paper page
- Gullestad, 1998, Serial exercise testing and prognosis in selected patients considered for cardiac transplantation, Am Heart J, 135, 221, 10.1016/S0002-8703(98)70085-7 · DOI
- Mehra, 2006, Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates—2006, J Heart Lung Transplant, 25, 1024, 10.1016/j.healun.2006.06.008 · DOI · Paper page
- de Lemos, 2003, B-type natriuretic peptide in cardiovascular disease, Lancet, 362, 316, 10.1016/S0140-6736(03)13976-1 · DOI · Paper page
- Siebert, 2006, Cost-effectiveness of using N-terminal pro-brain natriuretic peptide to guide the diagnostic assessment and management of dyspneic patients in the emergency department, Am J Cardiol, 98, 800, 10.1016/j.amjcard.2006.06.005 · DOI
- Gackowski, 2004, Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure, Eur Heart J, 25, 1788, 10.1016/j.ehj.2004.07.038 · DOI
- Bayes-Genis, 2004, N-terminal probrain natriuretic peptide (NT-proBNP) in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricular dysfunction, Eur J Heart Fail, 6, 301, 10.1016/j.ejheart.2003.12.013 · DOI · Paper page
- Dao, 2001, Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting, J Am Coll Cardiol, 37, 379, 10.1016/S0735-1097(00)01156-6 · DOI · Paper page
- Worster, 2008, Diagnostic accuracy of BNP and NT-proBNP in patients presenting to acute care settings with dyspnea: a systematic review, Clin Biochem, 41, 250, 10.1016/j.clinbiochem.2007.08.008 · DOI
- O'Donoghue, 2007, Usefulness of aminoterminal pro-brain natriuretic peptide testing for the diagnostic and prognostic evaluation of dyspneic patients with diabetes mellitus seen in the emergency department (from the PRIDE Study), Am J Cardiol, 100, 1336, 10.1016/j.amjcard.2007.06.020 · DOI
- Silvers, 2007, Clinical policy: Critical issues in the evaluation and management of adult patients presenting to the emergency department with acute heart failure syndromes, Ann Emerg Med, 49, 627, 10.1016/j.annemergmed.2006.10.024 · DOI
- Gibbons, 2002, ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines), J Am Coll Cardiol, 40, 1531, 10.1016/S0735-1097(02)02164-2 · DOI · Paper page
- Vitarelli, 2003, The role of echocardiography in the diagnosis and management of heart failure, Heart Fail Rev, 8, 181, 10.1023/A:1023001104207 · DOI
- Ritchie, 1995, Guidelines for clinical use of cardiac radionuclide imaging, J Am Coll Cardiol, 25, 521, 10.1016/0735-1097(95)90027-6 · DOI · Paper page
- Bello, 2003, Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy, Circulation, 108, 1945, 10.1161/01.CIR.0000095029.57483.60 · DOI · Paper page
- Troughton, 2000, Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations, Lancet, 355, 1126, 10.1016/S0140-6736(00)02060-2 · DOI · Paper page
- Weinfeld, 1999, Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure, Am Heart J, 138, 285, 10.1016/S0002-8703(99)70113-4 · DOI · Paper page
- Maisel, 2001, B-type natriuretic peptide levels: a potential novel “white count” for congestive heart failure, J Card Fail, 7, 183, 10.1054/jcaf.2001.24609 · DOI
- Mueller, 2004, Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea, N Engl J Med, 350, 647, 10.1056/NEJMoa031681 · DOI · Paper page
- Mehra, 2004, Obesity and suppressed B-type natriuretic peptide levels in heart failure, J Am Coll Cardiol, 43, 1590, 10.1016/j.jacc.2003.10.066 · DOI · Paper page
- Wright, 2003, Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial, J Am Coll Cardiol, 42, 1793, 10.1016/j.jacc.2003.05.011 · DOI · Paper page
- Tang, 2003, Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure, Circulation, 108, 2964, 10.1161/01.CIR.0000106903.98196.B6 · DOI · Paper page
- Mahdyoon, 1989, Radiographic pulmonary congestion in end-stage congestive heart failure, Am J Cardiol, 63, 625, 10.1016/0002-9149(89)90912-0 · DOI
- Aaronson, 1997, Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation, Circulation, 95, 2660, 10.1161/01.CIR.95.12.2660 · DOI · Paper page
- Levy, 2006, The Seattle Heart Failure Model: prediction of survival in heart failure, Circulation, 113, 1424, 10.1161/CIRCULATIONAHA.105.584102 · DOI · Paper page
- Butler, 2004, Selection of patients for heart transplantation in the current era of heart failure therapy, J Am Coll Cardiol, 43, 787, 10.1016/j.jacc.2003.08.058 · DOI
- Zipes, 2006, J Am Coll Cardiol, 48, e247, 10.1016/j.jacc.2006.07.010 · DOI · Paper page
- 1983, A placebo-controlled trial of captopril in refractory chronic congestive heart failure, J Am Coll Cardiol, 2, 755, 10.1016/S0735-1097(83)80316-7 · DOI · Paper page
- Garg, 1995, Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure, JAMA, 273, 1450, 10.1001/jama.1995.03520420066040 · DOI · Paper page
- Sharpe, 1984, Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study, Circulation, 70, 271, 10.1161/01.CIR.70.2.271 · DOI · Paper page
- Chalmers, 1987, Placebo-controlled study of lisinopril in congestive heart failure: a multicentre study, J Cardiovasc Pharmacol, 9, S89, 10.1097/00005344-198700003-00021 · DOI
- Cleland, 1984, Captopril in heart failure, Br Heart J, 52, 530, 10.1136/hrt.52.5.530 · DOI · Paper page
- Cleland, 1985, Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state, Br Heart J, 54, 305, 10.1136/hrt.54.3.305 · DOI · Paper page
- Cowley, 1982, Captopril therapy for heart failure, Lancet, 2, 730, 10.1016/S0140-6736(82)90920-5 · DOI
- Bayliss, 1985, Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin, Br Med J (Clin Res Ed), 290, 1861, 10.1136/bmj.290.6485.1861 · DOI
- Drexler, 1989, Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure, Circulation, 79, 491, 10.1161/01.CIR.79.3.491 · DOI · Paper page
- Erhardt, 1995, Fosinopril attenuates clinical deterioration and improves exercise tolerance in patients with heart failure, Eur Heart J, 16, 1892, 10.1093/oxfordjournals.eurheartj.a060844 · DOI
- 1987, Effects of enalapril on mortality in severe congestive heart failure, N Engl J Med, 316, 1429, 10.1056/NEJM198706043162301 · DOI · Paper page
- 1999, The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial, Lancet, 353, 9, 10.1016/S0140-6736(98)11181-9 · DOI · Paper page
- 2001, A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure, N Engl J Med, 344, 1659, 10.1056/NEJM200105313442202 · DOI · Paper page
- Poole-Wilson, 2003, Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial, Lancet, 362, 7, 10.1016/S0140-6736(03)13800-7 · DOI · Paper page
- 1999, Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF), Lancet, 353, 2001, 10.1016/S0140-6736(99)04440-2 · DOI · Paper page
- Lechat, 1998, Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials, Circulation, 98, 1184, 10.1161/01.CIR.98.12.1184 · DOI · Paper page
- Packer, 1996, The effect of carvedilol on morbidity and mortality in patients with chronic heart failure, N Engl J Med, 334, 1349, 10.1056/NEJM199605233342101 · DOI · Paper page
- Dargie, 2001, Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial, Lancet, 357, 1385, 10.1016/S0140-6736(00)04560-8 · DOI · Paper page
- Cleland, 2003, Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial, Lancet, 362, 14, 10.1016/S0140-6736(03)13801-9 · DOI · Paper page
- Fisher, 1994, Beneficial effects of metoprolol in heart failure associated with coronary artery disease: a randomized trial, J Am Coll Cardiol, 23, 943, 10.1016/0735-1097(94)90641-6 · DOI · Paper page
- Metra, 1994, Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy, J Am Coll Cardiol, 24, 1678, 10.1016/0735-1097(94)90174-0 · DOI · Paper page
- Olsen, 1995, Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study, J Am Coll Cardiol, 25, 1225, 10.1016/0735-1097(95)00012-S · DOI · Paper page
- Krum, 1995, Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure, Circulation, 92, 1499, 10.1161/01.CIR.92.6.1499 · DOI · Paper page
- Waagstein, 1993, Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy, Lancet, 342, 1441, 10.1016/0140-6736(93)92930-R · DOI · Paper page
- 1994, Circulation, The Cardiac Insufficiency Bisoprolol Study (CIBIS), 90, 1765
- Packer, 1996, Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure, Circulation, 94, 2793, 10.1161/01.CIR.94.11.2793 · DOI · Paper page
- Colucci, 1996, Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure, Circulation, 94, 2800, 10.1161/01.CIR.94.11.2800 · DOI · Paper page
- 1997, Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease, Lancet, 349, 375, 10.1016/S0140-6736(97)80008-6 · DOI · Paper page
- Gottlieb, 1993, Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure, Circulation, 88, 1602, 10.1161/01.CIR.88.4.1602 · DOI · Paper page
- Crozier, 1995, Losartan in heart failure, Circulation, 91, 691, 10.1161/01.CIR.91.3.691 · DOI · Paper page
- Riegger, 1999, Improvement in exercise tolerance and symptoms of congestive heart failure during treatment with candesartan cilexetil, Circulation, 100, 2224, 10.1161/01.CIR.100.22.2224 · DOI · Paper page
- Sharma, 2000, Meta-analysis of observed mortality data from all-controlled, double- blind, multiple-dose studies of losartan in heart failure, Am J Cardiol, 85, 187, 10.1016/S0002-9149(99)00646-3 · DOI
- McKelvie, 1999, Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study, Circulation, 100, 1056, 10.1161/01.CIR.100.10.1056 · DOI · Paper page
- Mazayev, 1998, Valsartan in heart failure patients previously untreated with an ACE inhibitor, Int J Cardiol, 65, 239, 10.1016/S0167-5273(98)00149-1 · DOI
- Wong, 2002, Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study, J Am Coll Cardiol, 40, 970, 10.1016/S0735-1097(02)02063-6 · DOI · Paper page
- Heerdink, 1998, NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics, Arch Intern Med, 158, 1108, 10.1001/archinte.158.10.1108 · DOI · Paper page
- Herchuelz, 1989, Interaction between nonsteroidal anti-inflammatory drugs and loop diuretics: modulation by sodium balance, J Pharmacol Exp Ther, 248, 1175, 10.1016/S0022-3565(25)24138-6 · DOI
- Gottlieb, 1992, Renal response to indomethacin in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy, Am J Cardiol, 70, 890, 10.1016/0002-9149(92)90733-F · DOI
- Bank, 1991, Local forearm vasodilation with intra-arterial administration of enalaprilat in humans, Clin Pharmacol Ther, 50, 314, 10.1038/clpt.1991.142 · DOI
- 1989, Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction, N Engl J Med, 321, 406, 10.1056/NEJM198908103210629 · DOI · Paper page
- 1992, Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction, N Engl J Med, 327, 227, 10.1056/NEJM199207233270403 · DOI · Paper page
- Pratt, 1989, The inverse relationship between baseline left ventricular ejection fraction and outcome of antiarrhythmic therapy: a dangerous imbalance in the risk-benefit ratio, Am Heart J, 118, 433, 10.1016/0002-8703(89)90254-8 · DOI
- Nilsson, 2008, Effects of group-based high-intensity aerobic interval training in patients with chronic heart failure, Am J Cardiol, 102, 1361, 10.1016/j.amjcard.2008.07.016 · DOI
- Mueller, 2007, Exercise capacity, physical activity patterns and outcomes six years after cardiac rehabilitation in patients with heart failure, Clin Rehabil, 21, 923, 10.1177/0269215507079097 · DOI
- Dracup, 2007, Effects of a home-based exercise program on clinical outcomes in heart failure, Am Heart J, 154, 877, 10.1016/j.ahj.2007.07.019 · DOI
- Jónsdóttir, 2006, The effect of physical training in chronic heart failure, Eur J Heart Fail, 8, 97, 10.1016/j.ejheart.2005.05.002 · DOI · Paper page
- Bokhari, 2004, Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS), Circulation, 110, 112, 10.1161/01.CIR.0000134957.51747.6E · DOI · Paper page
- Mark, 2006, Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT), Circulation, 114, 135, 10.1161/CIRCULATIONAHA.105.581884 · DOI · Paper page
- Hebert, 2006, Expansion of heart failure device therapy into a rural indigent population in Louisiana: potential economic and health policy implications, J Card Fail, 12, 689, 10.1016/j.cardfail.2006.08.214 · doi:10.1016/j.cardfail.2006.08.214
- Knight, 1999, Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator, J Am Coll Cardiol, 33, 1964, 10.1016/S0735-1097(99)00148-5 · DOI · Paper page
- Klein, 2000, The MUSTT study: evaluating testing and treatment, J Interv Card Electrophysiol, 4, 45, 10.1023/A:1009862028599 · DOI
- Moss, 2002, Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction, N Engl J Med, 346, 877, 10.1056/NEJMoa013474 · DOI · Paper page
- Hohnloser, 2000, The defibrillator in acute myocardial infarction trial (DINAMIT): study protocol, Am Heart J, 140, 735, 10.1067/mhj.2000.110088 · DOI
- Beshai, 2007, Cardiac-resynchronization therapy in heart failure with narrow QRS complexes, N Engl J Med, 357, 2461, 10.1056/NEJMoa0706695 · DOI · Paper page
- Cleland, 2005, The effect of cardiac resynchronization on morbidity and mortality in heart failure, N Engl J Med, 352, 1539, 10.1056/NEJMoa050496 · DOI · Paper page
- Higgins, 2003, Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias, J Am Coll Cardiol, 42, 1454, 10.1016/S0735-1097(03)01042-8 · DOI · Paper page
- Xiao, 1996, Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy, Int J Cardiol, 53, 163, 10.1016/0167-5273(95)02502-2 · DOI · Paper page
- Shamim, 1999, Intraventricular conduction delay: a prognostic marker in chronic heart failure, Int J Cardiol, 70, 171, 10.1016/S0167-5273(99)00077-7 · DOI · Paper page
- Unverferth, 1984, Factors influencing the one-year mortality of dilated cardiomyopathy, Am J Cardiol, 54, 147, 10.1016/0002-9149(84)90320-5 · DOI · Paper page
- Blanc, 1997, Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study, Circulation, 96, 3273, 10.1161/01.CIR.96.10.3273 · DOI · Paper page
- Kass, 1999, Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay, Circulation, 99, 1567, 10.1161/01.CIR.99.12.1567 · DOI · Paper page
- Toussaint, 2000, Biventricular pacing in severe heart failure patients reverses electromechanical dyssynchronization from apex to base, Pacing Clin Electrophysiol, 23, 1731, 10.1111/j.1540-8159.2000.tb07006.x · DOI
- Nelson, 2000, Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block, Circulation, 102, 3053, 10.1161/01.CIR.102.25.3053 · DOI · Paper page
- Young, 2003, Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial, JAMA, 289, 2685, 10.1001/jama.289.20.2685 · DOI
- McAlister, 2004, Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials, J Am Coll Cardiol, 44, 810
- Leclercq, 2002, Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation, Eur Heart J, 23, 1780, 10.1053/euhj.2002.3232 · DOI · Paper page
- Leon, 2002, Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effect of upgrading to biventricular pacing after chronic right ventricular pacing, J Am Coll Cardiol, 39, 1258, 10.1016/S0735-1097(02)01779-5 · DOI · Paper page
- Juurlink, 2003, Drug-drug interactions among elderly patients hospitalized for drug toxicity, JAMA, 289, 1652, 10.1001/jama.289.13.1652 · DOI · Paper page
- Juurlink, 2004, Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study, N Engl J Med, 351, 543, 10.1056/NEJMoa040135 · DOI · Paper page
- Svensson, 2004, How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure?, J Card Fail, 10, 297, 10.1016/j.cardfail.2003.10.012 · DOI
- Carson, 1999, Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials, J Card Fail, 5, 178, 10.1016/S1071-9164(99)90001-5 · DOI · Paper page
- Stevenson, 2007, Management of atrial fibrillation in patients with heart failure, Heart Rhythm, 4, S28, 10.1016/j.hrthm.2006.12.003 · DOI
- Heist, 2006, Atrial fibrillation and congestive heart failure: risk factors, mechanisms, and treatment, Prog Cardiovasc Dis, 48, 256, 10.1016/j.pcad.2005.09.001 · DOI
- Van Gelder, 2002, A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation, N Engl J Med, 347, 1834, 10.1056/NEJMoa021375 · DOI · Paper page
- 1988, Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure, JAMA, 259, 539, 10.1001/jama.1988.03720040031022 · DOI · Paper page
- Dobbs, 1977, Maintenance digoxin after an episode of heart failure: placebo-controlled trial in outpatients, Br Med J, 1, 749, 10.1136/bmj.1.6063.749 · DOI · Paper page
- Lee, 1982, Heart failure in outpatients: a randomized trial of digoxin versus placebo, N Engl J Med, 306, 699, 10.1056/NEJM198203253061202 · DOI · Paper page
- Guyatt, 1988, A controlled trial of digoxin in congestive heart failure, Am J Cardiol, 61, 371, 10.1016/0002-9149(88)90947-2 · DOI · Paper page
- DiBianco, 1989, A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure, N Engl J Med, 320, 677, 10.1056/NEJM198903163201101 · DOI · Paper page
- Uretsky, 1993, Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial, J Am Coll Cardiol, 22, 955, 10.1016/0735-1097(93)90403-N · DOI · Paper page
- Packer, 1993, Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors, N Engl J Med, 329, 1, 10.1056/NEJM199307013290101 · DOI · Paper page
- Cohn, 1993, The Vasodilator-Heart Failure Trials (V-HeFT), Circulation, 87, VI1
- Cazeau, 2001, Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay, N Engl J Med, 344, 873, 10.1056/NEJM200103223441202 · DOI · Paper page
- Loeb, 1993, Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure, Circulation, 87, VI78
- 1988, The effect of diltiazem on mortality and reinfarction after myocardial infarction, N Engl J Med, 319, 385, 10.1056/NEJM198808183190701 · DOI · Paper page
- Reed, 2004, Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT), Am Heart J, 148, 122, 10.1016/j.ahj.2003.12.040 · DOI
- Setaro, 1990, Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance, Am J Cardiol, 66, 981, 10.1016/0002-9149(90)90937-V · DOI · Paper page
- Packer, 1996, Effect of amlodipine on morbidity and mortality in severe chronic heart failure, N Engl J Med, 335, 1107, 10.1056/NEJM199610103351504 · DOI · Paper page
- McKelvie, 1995, Effects of exercise training in patients with congestive heart failure: a critical review, J Am Coll Cardiol, 25, 789, 10.1016/0735-1097(94)00428-S · DOI · Paper page
- Chati, 1996, Physical deconditioning may be a mechanism for the skeletal muscle energy phosphate metabolism abnormalities in chronic heart failure, Am Heart J, 131, 560, 10.1016/S0002-8703(96)90537-2 · DOI
- Sinoway, 1988, Effect of conditioning and deconditioning stimuli on metabolically determined blood flow in humans and implications for congestive heart failure, Am J Cardiol, 62, 45E, 10.1016/S0002-9149(88)80010-9 · DOI
- Mancini, 1992, Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure, Circulation, 85, 1364, 10.1161/01.CIR.85.4.1364 · DOI · Paper page
- Packer, 1991, Hemodynamic consequences of antiarrhythmic drug therapy in patients with chronic heart failure, J Cardiovasc Electrophysiol, 2, S240
- Torp-Pedersen, 1999, Dofetilide in patients with congestive heart failure and left ventricular dysfunction, N Engl J Med, 341, 857, 10.1056/NEJM199909163411201 · DOI · Paper page
- Packer, 1987, Calcium-channel blockade in the management of severe chronic congestive heart failure: a bridge too far, Circulation, 75, V56
- Packer, 1986, Hormone-electrolyte interactions in the pathogenesis of lethal cardiac arrhythmias in patients with congestive heart failure, Am J Med, 80, 23, 10.1016/0002-9343(86)90337-2 · DOI
- Packer, 1987, Adaptive and maladaptive actions of angiotensin II in patients with severe congestive heart failure, Am J Kidney Dis, 10, 66
- Reid, 1986, Epinephrine-induced hypokalemia: the role of beta adrenoceptors, Am J Cardiol, 57, 23F, 10.1016/0002-9149(86)90884-2 · DOI
- Packer, 1990, Potential role of potassium as a determinant of morbidity and mortality in patients with systemic hypertension and congestive heart failure, Am J Cardiol, 65, 45E, 10.1016/0002-9149(90)90251-U · DOI
- Schwartz, 1978, Potassium-related cardiac arrhythmias and their treatment, Angiology, 29, 194, 10.1177/000331977802900302 · DOI
- Rude, 1989, Physiology of magnesium metabolism and the important role of magnesium in potassium deficiency, Am J Cardiol, 63, 31G, 10.1016/0002-9149(89)90216-6 · DOI
- Rich, 1995, A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure, N Engl J Med, 333, 1190, 10.1056/NEJM199511023331806 · DOI · Paper page
- Shah, 1998, Prevention of hospitalizations for heart failure with an interactive home monitoring program, Am Heart J, 135, 373, 10.1016/S0002-8703(98)70310-2 · DOI · Paper page
- Fonarow, 1997, Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure, J Am Coll Cardiol, 30, 725, 10.1016/S0735-1097(97)00208-8 · DOI · Paper page
- Philbin, 1999, Comprehensive multidisciplinary programs for the management of patients with congestive heart failure, J Gen Intern Med, 14, 130, 10.1046/j.1525-1497.1999.00291.x · DOI
- Pitt, 2001, The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction, Cardiovasc Drugs Ther, 15, 79, 10.1023/A:1011119003788 · DOI · Paper page
- Uretsky, 2000, Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial, Circulation, 102, 611, 10.1161/01.CIR.102.6.611 · DOI · Paper page
- Luu, 1989, Diverse mechanisms of unexpected cardiac arrest in advanced heart failure, Circulation, 80, 1675, 10.1161/01.CIR.80.6.1675 · DOI · Paper page
- 1981, Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction, N Engl J Med, 304, 801, 10.1056/NEJM198104023041401 · DOI · Paper page
- 1982, A randomized trial of propranolol in patients with acute myocardial infarction, JAMA, 247, 1707, 10.1001/jama.1982.03320370021023 · DOI · Paper page
- Packer, 1985, Sudden unexpected death in patients with congestive heart failure: a second frontier, Circulation, 72, 681, 10.1161/01.CIR.72.4.681 · DOI · Paper page
- Kjekshus, 1990, Arrhythmias and mortality in congestive heart failure, Am J Cardiol, 65, 42I, 10.1016/0002-9149(90)90125-K · DOI · Paper page
- Packer, 1992, Lack of relation between ventricular arrhythmias and sudden death in patients with chronic heart failure, Circulation, 85, I50
- Twidale, 1998, Comparison of the effects of AV nodal ablation versus AV nodal modification in patients with congestive heart failure and uncontrolled atrial fibrillation, Pacing Clin Electrophysiol, 21, 641, 10.1111/j.1540-8159.1998.tb00119.x · DOI
- Coplen, 1990, Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion, Circulation, 82, 1106, 10.1161/01.CIR.82.4.1106 · DOI · Paper page
- Waldo, 1996, Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction, Lancet, 348, 7, 10.1016/S0140-6736(96)02149-6 · DOI · Paper page
- Pratt, 1998, Mortality in the Survival With ORal D-sotalol (SWORD) trial: why did patients die?, Am J Cardiol, 81, 869, 10.1016/S0002-9149(98)00006-X · DOI
- Du, 1995, Sympatholytic action of intravenous amiodarone in the rat heart, Circulation, 91, 462, 10.1161/01.CIR.91.2.462 · DOI
- Doval, 1994, Randomised trial of low-dose amiodarone in severe congestive heart failure, Lancet, 344, 493, 10.1016/S0140-6736(94)91895-3 · DOI · Paper page
- Singh, 1995, Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia, N Engl J Med, 333, 77, 10.1056/NEJM199507133330201 · DOI · Paper page
- Massie, 1996, Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure, Circulation, 93, 2128, 10.1161/01.CIR.93.12.2128 · DOI · Paper page
- Kadish, 2004, Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy, N Engl J Med, 350, 2151, 10.1056/NEJMoa033088 · DOI · Paper page
- Soejima, 2001, Catheter ablation in patients with multiple and unstable ventricular tachycardias after myocardial infarction: short ablation lines guided by reentry circuit isthmuses and sinus rhythm mapping, Circulation, 104, 664, 10.1161/hc3101.093764 · DOI · Paper page
- Silverman, 1995, Prognostic value of the signal-averaged electrocardiogram and a prolonged QRS in ischemic and nonischemic cardiomyopathy, Am J Cardiol, 75, 460, 10.1016/S0002-9149(99)80581-5 · DOI
- Fried, 1999, Electrical and hemodynamic correlates of the maximal rate of pressure increase in the human left ventricle, J Card Fail, 5, 8, 10.1016/S1071-9164(99)90019-2 · DOI
- Wilensky, 1988, Serial electrocardiographic changes in idiopathic dilated cardiomyopathy confirmed at necropsy, Am J Cardiol, 62, 276, 10.1016/0002-9149(88)90225-1 · DOI · Paper page
- Grines, 1989, Functional abnormalities in isolated left bundle branch block, Circulation, 79, 845, 10.1161/01.CIR.79.4.845 · DOI · Paper page
- Xiao, 1991, Effect of left bundle branch block on diastolic function in dilated cardiomyopathy, Br Heart J, 66, 443, 10.1136/hrt.66.6.443 · DOI · Paper page
- Takeshita, 1974, Effect of intermittent left bundle branch block on left ventricular performance, Am J Med, 56, 251, 10.1016/0002-9343(74)90604-4 · DOI
- Anderson, 1991, Hemodynamic and clinical benefits with intravenous milrinone in severe chronic heart failure: results of a multicenter study in the United States, Am Heart J, 121, 1956, 10.1016/0002-8703(91)90832-3 · DOI
- Hatzizacharias, 1999, Intermittent milrinone effect on long-term hemodynamic profile in patients with severe congestive heart failure, Am Heart J, 138, 241, 10.1016/S0002-8703(99)70107-9 · DOI
- Cadel, 1986, Effects of digoxin, placebo and ibopamine on exercise tolerance and cardiac rhythm of patients with chronic post-infarct left ventricular failure, Arzneimittelforschung, 36, 376
- Colucci, 1993, Efficacy of phosphodiesterase inhibition with milrinone in combination with converting enzyme inhibitors in patients with heart failure, J Am Coll Cardiol, 22, 113A, 10.1016/0735-1097(93)90473-E · DOI
- DiBianco, 1984, Oral amrinone for the treatment of chronic congestive heart failure: results of a multicenter randomized double-blind and placebo-controlled withdrawal study, J Am Coll Cardiol, 4, 855, 10.1016/S0735-1097(84)80044-3 · DOI
- Glover, 1985, Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade?, Br Heart J, 53, 208, 10.1136/hrt.53.2.208 · DOI
- Goldberg, 1991, Effectiveness of imazodan for treatment of chronic congestive heart failure, Am J Cardiol, 68, 631, 10.1016/0002-9149(91)90356-P · DOI
- Massie, 1985, Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial, Circulation, 71, 963, 10.1161/01.CIR.71.5.963 · DOI · Paper page
- Narahara, 1991, Oral enoximone therapy in chronic heart failure: a placebo-controlled randomized trial, Am Heart J, 121, 1471, 10.1016/0002-8703(91)90154-A · DOI
- Roubin, 1984, Beta-adrenergic stimulation of the failing ventricle: a double-blind, randomized trial of sustained oral therapy with prenalterol, Circulation, 69, 955, 10.1161/01.CIR.69.5.955 · DOI
- Uretsky, 1990, Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure, Circulation, 82, 774, 10.1161/01.CIR.82.3.774 · DOI · Paper page
- van Veldhuisen, 1993, Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT), J Am Coll Cardiol, 22, 1564, 10.1016/0735-1097(93)90579-P · DOI · Paper page
- Weber, 1982, Pirbuterol, an oral beta-adrenergic receptor agonist, in the treatment of chronic cardiac failure, Circulation, 66, 1262, 10.1161/01.CIR.66.6.1262 · DOI
- Cohn, 1998, A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure, N Engl J Med, 339, 1810, 10.1056/NEJM199812173392503 · DOI · Paper page
- Cowley, 1994, Treatment of severe heart failure: quantity or quality of life?, Br Heart J, 72, 226, 10.1136/hrt.72.3.226 · DOI
- Feldman, 1993, Effects of vesnarinone on morbidity and mortality in patients with heart failure, N Engl J Med, 329, 149, 10.1056/NEJM199307153290301 · DOI · Paper page
- Hampton, 1997, Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure, Lancet, 349, 971, 10.1016/S0140-6736(96)10488-8 · DOI · Paper page
- Lubsen, 1996, Effect of pimobendan on exercise capacity in patients with heart failure: main results from the Pimobendan in Congestive Heart Failure (PICO) trial, Heart, 76, 223, 10.1136/hrt.76.3.223 · DOI · Paper page
- Packer, 1991, Effect of oral milrinone on mortality in severe chronic heart failure, N Engl J Med, 325, 1468, 10.1056/NEJM199111213252103 · DOI · Paper page
- Cesario, 1998, Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: a preliminary study, Am Heart J, 135, 121, 10.1016/S0002-8703(98)70352-7 · DOI
- Leier, 1998, Parenteral inotropic support for advanced congestive heart failure, Prog Cardiovasc Dis, 41, 207, 10.1016/S0033-0620(98)80056-X · DOI
- Marius-Nunez, 1996, Intermittent inotropic therapy in an outpatient setting: a cost- effective therapeutic modality in patients with refractory heart failure, Am Heart J, 132, 805, 10.1016/S0002-8703(96)90315-4 · DOI
- Applefeld, 1987, Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: clinical experience in 21 patients, Am Heart J, 114, 589, 10.1016/0002-8703(87)90757-5 · DOI
- Elis, 1998, Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: a randomized, double-blind, placebo-controlled study, Clin Pharmacol Ther, 63, 682, 10.1016/S0009-9236(98)90092-3 · DOI
- Brater, 1980, Furosemide in patients with heart failure: shift in dose-response curves, Clin Pharmacol Ther, 28, 182, 10.1038/clpt.1980.148 · DOI
- Dormans, 1996, Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion, J Am Coll Cardiol, 28, 376, 10.1016/0735-1097(96)00161-1 · DOI · Paper page
- Cotter, 1997, Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure, Clin Pharmacol Ther, 62, 187, 10.1016/S0009-9236(97)90067-9 · DOI
- Faris, 2006, Diuretics for heart failure, Cochrane Database Syst Rev, 10.1002/14651858.CD003838.pub2 · DOI
- Costanzo, 2005, Early ultrafiltration in patients with decompensated heart failure and diuretic resistance, J Am Coll Cardiol, 46, 2047, 10.1016/j.jacc.2005.05.099 · DOI · Paper page
- Domanski, 2003, Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD), J Am Coll Cardiol, 42, 705, 10.1016/S0735-1097(03)00765-4 · DOI · Paper page
- Cicoira, 2002, Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure, J Am Coll Cardiol, 40, 304, 10.1016/S0735-1097(02)01965-4 · DOI · Paper page
- Faris, 2002, Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials, Int J Cardiol, 82, 149, 10.1016/S0167-5273(01)00600-3 · DOI · Paper page
- Jessup, 2006, J Heart Lung Transplant, 25, 1003, 10.1016/j.healun.2006.06.007 · DOI
- McAlister, 2001, A systematic review of randomized trials of disease management programs in heart failure, Am J Med, 110, 378, 10.1016/S0002-9343(00)00743-9 · DOI · Paper page
- Whellan, 2005, Metaanalysis and review of heart failure disease management randomized controlled clinical trials, Am Heart J, 149, 722, 10.1016/j.ahj.2004.09.023 · DOI · Paper page
- Yancy, 2007, The Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial for advanced heart failure: study rationale and design, Am Heart J, 153, 478, 10.1016/j.ahj.2007.02.004 · DOI
200 of 311 shown
Cited by
2005 WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192065 · Cited by 3,720
Self-citationHunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.013 · Cited by 1,374
Self-citationBosch, X., Rovira, M., Sitges, M., Domènech, A., Ortiz-Pérez, J. T., de Caralt, T. M., Morales-Ruiz, M., Perea, R. J., Monzó, M., & Esteve, J. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.072 · Cited by 632
Cardiopoietic Stem Cell Therapy in Heart Failure
Bartunek, J., Behfar, A., Dolatabadi, D., Vanderheyden, M., Ostojic, M., Dens, J., El Nakadi, B., Banovic, M., Beleslin, B., Vrolix, M., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.071 · Cited by 493
The Role of Cardiovascular Magnetic Resonance Imaging in Heart Failure
Karamitsos, T. D., Francis, J. M., Myerson, S., Selvanayagam, J. B., & Neubauer, S. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.094 · Cited by 467
Metadata
- Authors
- Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., & Yancy, C. W.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2009-04
- Volume
- 53
- Issue
- 15
- Pages
- 1343-1382
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W3023105181
- Cited by
- 215
- References
- 28
- FWCI
- 18.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 1567 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults. https://app.cochat.ai/papers/10.1016/j.jacc.2008.11.009
- The paper
- Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., & Yancy, C. W. (2009). 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2008.11.009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.